About: Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.05 (+1.24%)
ALT NASDAQ Altimmune Inc
Altimmune Inc share price
ALT price activity
Last Price
$2.050
Change (24hr)
0.03 USD (1.24%)
Volume
39.12K
Volume (4w avg)
-
Open
$2.04
Day Range
$2.03 - $2.05
Previous Close
$2.02
Last Trade
03 Nov, 2:33 pm GMT+0
Delayed
03 Nov, 2:33 pm GMT+0
ALT price performance
Delayed
03 Nov, 2:33 pm GMT+0
ALT details
ALT Market Signals